mlsanityData to 13 Oct 2026

Efficient and Debiased Learning of Average Hazard Under Non-Proportional Hazards

arXiv 2602.13475 ↗First posted 13 Feb 2026stat.ME stat.AP stat.MLcited by 0

Not on the map. Why?

Abstract (arXiv)

The hazard ratio from the Cox proportional hazards model is a ubiquitous summary of treatment effect. However, when hazards are non-proportional, the hazard ratio can lose a stable causal interpretation and become study-dependent because it effectively averages time-varying effects with weights determined by follow-up and censoring. We consider the average hazard (AH) as an alternative causal estimand: a population-level person-time event rate that remains well-defined and interpretable without assuming proportional hazards. Although AH can be estimated nonparametrically and regression-style adjustments have been proposed, existing approaches do not provide a general framework for flexible, high-dimensional nuisance estimation with valid sqrt{n} inference. We address this gap by developing a semiparametric, doubly robust framework for covariate-adjusted AH. We establish pathwise differentiability of AH in the nonparametric model, derive its efficient influence function, and construct cross-fitted, debiased estimators that leverage machine learning for nuisance estimation while retaining asymptotically normal, sqrt{n}-consistent inference under mild product-rate conditions. Simulations demonstrate that the proposed estimator achieves small bias and near-nominal confidence-interval coverage across proportional and non-proportional hazards settings, including crossing-hazards regimes where Cox-based summaries can be unstable. We illustrate practical utility in comparative effectiveness research by comparing immunotherapy regimens for advanced melanoma using SEER-Medicare linked data.

Key facts. No citing papers in the map yet (data through 13 Oct 2026). Builds on 2 of its 30 references that are in the map. First posted on arXiv 13 Feb 2026.

Builds on

2 of 30 references.

References · 2

  1. 2021Inference for treatment-specific survival curves using machine learningcited by 8
  2. 2024A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time-to-Event Outcomes Using Average Hazard with Survival Weightcited by 1

Built on by

Not cited yet.